Ipsen is withdrawing tazemetostat from all markets following signals of secondary hematologic malignancies observed in SYMPHONY-1 evaluating tazemetostat plus lenalidomide/rituximab versus ...

Purchaser coalition data show accelerating uptake: direct contracts rose from 18.7% (2023) to 27.6% (2025), with an additional 26.7% evaluating adoption over one to three years. Cost pressure remains ...

In a fifth segment from an extended interview with Managed Healthcare Executive, Jaewon Ryu, M.D., J.D., identified the Care Without Delay program and the value-based care guides as central elements ...

IBX’s Rodrigo Cerdá, M.D., M.P.H., back Jefferson Health primary care screening to catch dementia care needs early and coordinate support.

In multivariable analysis, six clinicopathologic variables were significantly associated with time to recurrence: ulceration, tumor thickness, tumor location, neurotropism (tumor growth along nerves), ...

Eric C. Hunter, MBA, has been president and CEO of CareOregon, the largest Medicaid managed care plan in Oregon, since 2016, ...

Dementia care often begins in the primary care setting; however, many cases of early cognitive decline go undetected, ...

Utah Republican State Sen. Kirk Cullimore, who sponsored the legislation creating Utah’s “regulatory mitigation” program to help court AI companies, said the mix of safeguards and technology ...

Jaewon Ryu, M.D., J.D., sees prevention and early recognition of disease as central to value-based care practices and ...

With the advent of the ACO programs 15 years ago — Medicare Shared Savings Program was launched as part of the implementation ...

FDA approval introduces first-in-class, once-daily oral TYK2 inhibition for active psoriatic arthritis, expanding deucravacitinib beyond its 2022 plaque psoriasis indication. POETYK PsA-1 and PsA-2 ...

Delaying onboarding until FDA approval reduces sunk-cost risk but can impede institutional learning and slow post-approval ...